Market Cap ₹292 Cr.
Stock P/E -27.9
P/B 1.8
Current Price ₹70.4
Book Value ₹ 39.6
Face Value 10
52W High ₹104.7
Dividend Yield 0%
52W Low ₹ 62
The Waterbase Ltd is engaged within the aquaculture enterprise. The Company is centred on manufacturing shrimp feed, processing shrimp and exporting processed shrimp. It operates in 2 business segments: Shrimp Feed Manufacturing and Processed Shrimp Exports. Its geographic segments are both in India and Overseas. It manufactures a number of shrimp feeds, consisting of Bay White, that's a brand for Vannamei shrimp (Litopenaeus vannamei) farming; Tiger Bay XL, a feed for modified farming of tiger shrimp; Ultra XL, that is formulated to meet dietary needs of tiger shrimp (Penaeus monodon), and Magnum, a feed for Scampi (Macrobrachium Rosenbergii). It additionally exports shrimp in diff forms, including instant quick freeze (IQF), block frozen and cooked to the geographies of Japan, the US and Europe. Its shrimp feed is bought across the coastal states of India. It has a shrimp processing plant and shrimp feed manufacturing plant in Andhra Pradesh, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 80 | 88 | 71 | 66 | 111 | 87 | 74 | 67 | 72 | 62 |
Other Income | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 4 |
Total Income | 80 | 88 | 71 | 67 | 112 | 87 | 74 | 68 | 73 | 66 |
Total Expenditure | 77 | 86 | 71 | 66 | 108 | 87 | 76 | 72 | 78 | 66 |
Operating Profit | 3 | 3 | -0 | 1 | 5 | 0 | -2 | -4 | -6 | -0 |
Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 0 | -3 | -2 | 1 | -3 | -5 | -6 | -9 | -3 |
Provision for Tax | 0 | 0 | -1 | -0 | 0 | -1 | -1 | -2 | -2 | -1 |
Profit After Tax | 1 | 0 | -2 | -2 | 1 | -2 | -4 | -5 | -6 | -2 |
Adjustments | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 |
Profit After Adjustments | 1 | 0 | -2 | -2 | 1 | -2 | -4 | -5 | -6 | -2 |
Adjusted Earnings Per Share | 0.1 | 0.1 | -0.6 | -0.5 | 0.2 | -0.6 | -1 | -1.2 | -1.5 | -0.6 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|
Net Sales | 322 | 212 | 299 | 304 | 339 | 275 |
Other Income | 2 | 3 | 9 | 3 | 3 | 5 |
Total Income | 325 | 214 | 308 | 307 | 343 | 281 |
Total Expenditure | 290 | 197 | 298 | 300 | 343 | 292 |
Operating Profit | 35 | 17 | 10 | 7 | -1 | -12 |
Interest | 3 | 1 | 1 | 2 | 3 | 4 |
Depreciation | 7 | 7 | 8 | 9 | 10 | 8 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 25 | 8 | 0 | -4 | -13 | -23 |
Provision for Tax | 6 | 2 | 0 | -1 | -3 | -6 |
Profit After Tax | 18 | 6 | 0 | -3 | -10 | -17 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 18 | 6 | 0 | -3 | -10 | -17 |
Adjusted Earnings Per Share | 4.5 | 1.4 | 0 | -0.8 | -2.5 | -4.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 12% | 17% | 0% | 0% |
Operating Profit CAGR | -114% | NAN% | 0% | 0% |
PAT CAGR | 0% | NAN% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -15% | -11% | -14% | 1% |
ROE Average | -6% | -3% | 1% | 1% |
ROCE Average | -5% | -2% | 3% | 3% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|
Shareholder's Funds | 184 | 190 | 186 | 183 | 173 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 5 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 69 | 70 | 70 | 69 | 65 |
Total Current Liabilities | 44 | 50 | 38 | 101 | 67 |
Total Liabilities | 302 | 310 | 294 | 353 | 304 |
Fixed Assets | 70 | 66 | 65 | 75 | 72 |
Other Non-Current Assets | 70 | 74 | 81 | 80 | 77 |
Total Current Assets | 163 | 170 | 149 | 198 | 156 |
Total Assets | 302 | 310 | 294 | 353 | 304 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | -9 | 11 | 0 | 25 | 4 |
Cash Flow from Operating Activities | 44 | 52 | 2 | -37 | 7 |
Cash Flow from Investing Activities | -4 | -53 | 28 | -15 | 1 |
Cash Flow from Financing Activities | -20 | -10 | -5 | 31 | -14 |
Net Cash Inflow / Outflow | 20 | -11 | 25 | -21 | -7 |
Closing Cash & Cash Equivalent | 11 | 0 | 25 | 4 | -3 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 4.46 | 1.43 | 0.02 | -0.84 | -2.52 |
CEPS(Rs) | 6.19 | 3.19 | 2.06 | 1.32 | -0.23 |
DPS(Rs) | 0 | 1 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 44.38 | 45.88 | 44.9 | 44.1 | 41.65 |
Core EBITDA Margin(%) | 10 | 6.68 | 0.22 | 1.33 | -1.21 |
EBIT Margin(%) | 8.52 | 4.52 | 0.39 | -0.74 | -3.02 |
Pre Tax Margin(%) | 7.7 | 3.82 | 0.11 | -1.44 | -3.91 |
PAT Margin (%) | 5.73 | 2.8 | 0.03 | -1.14 | -3.08 |
Cash Profit Margin (%) | 7.95 | 6.24 | 2.86 | 1.8 | -0.28 |
ROA(%) | 6.12 | 1.93 | 0.02 | -1.07 | -3.18 |
ROE(%) | 10.06 | 3.16 | 0.04 | -1.89 | -5.88 |
ROCE(%) | 13.99 | 4.95 | 0.63 | -1.11 | -4.89 |
Receivable days | 84.21 | 105.24 | 52.82 | 75.33 | 69.49 |
Inventory Days | 70.65 | 104.02 | 71.52 | 80.43 | 85 |
Payable days | 32.85 | 65.46 | 45.75 | 57.4 | 55.19 |
PER(x) | 19.81 | 70.32 | 4563.54 | 0 | 0 |
Price/Book(x) | 1.99 | 2.19 | 1.84 | 1.3 | 1.6 |
Dividend Yield(%) | 0 | 1 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.1 | 1.7 | 1.01 | 0.82 | 0.84 |
EV/Core EBITDA(x) | 10.29 | 21.32 | 31.18 | 37.37 | -388.49 |
Net Sales Growth(%) | 0 | -34.4 | 41.23 | 1.79 | 11.57 |
EBIT Growth(%) | 0 | -65.18 | -87.7 | -292.22 | -353.57 |
PAT Growth(%) | 0 | -68.01 | -98.73 | -4742.19 | -200.59 |
EPS Growth(%) | 0 | -68.01 | -98.73 | -4737.02 | -200.6 |
Debt/Equity(x) | 0.07 | 0 | 0 | 0.21 | 0.15 |
Current Ratio(x) | 3.68 | 3.4 | 3.91 | 1.96 | 2.33 |
Quick Ratio(x) | 2.27 | 2.23 | 2.36 | 1.22 | 1.09 |
Interest Cover(x) | 10.48 | 6.46 | 1.4 | -1.07 | -3.41 |
Total Debt/Mcap(x) | 0.03 | 0 | 0 | 0.16 | 0.09 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 68.99 | 69.04 | 69.04 | 69.04 | 69.04 | 69.04 | 69.04 | 69.04 | 69.04 | 69.04 |
FII | 0.07 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 |
Public | 30.94 | 30.95 | 30.95 | 30.95 | 30.95 | 30.95 | 30.95 | 30.94 | 30.95 | 30.95 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About